CAD Study

Cross-source consensus on CAD Study from 1 sources and 5 claims.

1 sources · 5 claims

Uses

CAD is an open-label feasibility study evaluating whether larger low-dose colchicine trials can be conducted in haemodialysis patients. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
CAD will enrol 100 haemodialysis patients from Guy’s and St Thomas’ NHS Foundation Trust dialysis units and clinics. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
CAD is not designed to determine whether colchicine improves clinical outcomes. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
CAD excludes peritoneal dialysis patients because study blood tests are aligned with routine haemodialysis sessions. — Colchicine and dialysis patients (CAD): protocol for a feasibility study
CAD uses a single-arm design to maximise tolerability data from recruited participants. — Colchicine and dialysis patients (CAD): protocol for a feasibility study